🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The COPACABANA study is designed as a single-centre, open, prospective tria...
Status
Completed
Location
National Institute of Cardiology
Start Date
2020-02-01
Trial ID
NCT04465526
Treatments Being Tested
This is a prospective, observational study designed to evaluate the role of...
Status
Terminated
Location
Penn Medicine / Lancaster General Hospital
Start Date
2019-03-27
Trial ID
NCT03800862
Treatments Being Tested
The purpose of this study is to demonstrate that intravenous regadenoson is...
Status
Completed
Location
Ochsner Medical Center
Start Date
2012-03
Trial ID
NCT01482169
Treatments Being Tested
This is a pilot study in a patient population with suspected coronary arter...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2014-05-16
Trial ID
NCT01949844
Treatments Being Tested
This is a Phase 3, prospective, open-label, international, multicentre stud...
Status
Completed
Location
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
Start Date
2018-06-05
Trial ID
NCT03354273
Treatments Being Tested
The purpose if this study is to examine how effective Regadenoson is in det...
Status
Completed
Location
Mayo Clinic
Start Date
2012-07-31
Trial ID
NCT01489176
Treatments Being Tested
We will test the hypothesis that a single dose of Regadenoson will produce ...
Status
Completed
Location
University of Utah
Start Date
2009-02
Trial ID
NCT00859833
Treatments Being Tested
Sickle cell disease (SCD) is an inherited blood disorder that causes the re...
Status
Completed
Location
Howard University Hospital
Start Date
2010-04
Trial ID
NCT01085201
Treatments Being Tested
It is been known for at least 20 years that the hemodynamic data, the amoun...
Status
Completed
Location
University of MD Cardiology Physicians
Start Date
2009-12
Trial ID
NCT01026012
Treatments Being Tested
Adenoscan® (adenosine) is an approved pharmacological stress agent indicate...
Status
Completed
Location
Multiple study locations (see Central Contact); CV Therapeutics, Inc.
Start Date
2004-04
Trial ID
NCT00208312
Treatments Being Tested